Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000425029

Medchemexpress LLC Veldoreotide TFA | 2126831-23-8 | 99.0% | 1237.33 | 5 MG
SDP

Catalog No. 5000425029
Encompass_Preferred

Veldoreotide TFA (DG3173) is a somatostatin analogue that binds to and activates somatostatin receptors (SSTR) 2, 4, and 5. It inhibits growth hormone (GH) secretion in adenomas and has potential use as a pain modulating agent.

  • Activates somatostatin receptors 2, 4, and 5
  • Inhibits growth hormone (GH) secretion in adenomas
  • May be used as a pain-modulating agent
  • Stimulates SST2, SST4, and SST5 receptors in HEK293 cells co-expressing these receptors with GIRK2 channels
  • Inhibits SST4-expressing BON-1 cells at 10 μM for 24 hours

Catalog No. 50-004-25029 Supplier Medchemexpress LLC Supplier No. HYP0024A5MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Veldoreotide TFA (DG3173) is a somatostatin analogue that binds to and activates somatostatin receptors (SSTR) 2, 4, and 5. It inhibits growth hormone (GH) secretion in adenomas and has potential use as a pain modulating agent.

  • Activates somatostatin receptors 2, 4, and 5
  • Inhibits growth hormone (GH) secretion in adenomas
  • May be used as a pain-modulating agent
  • Stimulates SST2, SST4, and SST5 receptors in HEK293 cells co-expressing these receptors with GIRK2 channels
  • Inhibits SST4-expressing BON-1 cells at 10 μM for 24 hours

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.